Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ·Healthcare·Biotechnology
$15.08
-0.07%
Mkt Cap $1.21B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (16 analysts)
$24.50
Range $21.00 – $28.00
Implied Upside
+62.5%
Consensus $24.50 vs current $15.08
NASDAQ·Healthcare·Biotechnology
$15.08
-0.07%
Mkt Cap $1.21B
Buy
6
Hold
0
Sell
0
Price Target (16 analysts)
$24.50
Range $21.00 – $28.00
+62.5%
Consensus $24.50 vs current $15.08